Of the 85,373 people included, 67,769 had type 2 diabetes and 17,604 people lived with obesity or cardiovascular risk, but without diabetes
The bigger concern is making sure you are consuming enough nutrients, calories, and water
The heavier the initial weight, the more pronounced this effect during weight loss
Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the PIONEER 7 trial
Start GLP-1 therapy the easy way with the NiceRx Microdose GLP-1 Program
The Online Prescription Process: From Intake to Medication Delivery The typical remote GLP-1 prescription pathway begins with an online questionnaire covering medical history, current symptoms, and treatment goals